Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (2832)	11/16/1997 2:22:00 AM
From: JOHN W.	Read Replies (1) \| Respond to of 6136

You wrote, <I simply indicated that resistant strains will develop eventually, and the time frame is dependent on many factors. I also indicated that I would put 2 years in the "short term" category.> Please educate me, since I am among the few that don't understand the science or biotechs. Where has it been stated or implied in any of these studies that "resistant strains will develop eventually". If this is simply your analysis, what is your reasoning that patients that remain undetectable for up to 30 months will eventually develop resistance in (x amount of time). Although dependent on many factors, have you any guess based on scientific/mathematical models that would suggest resistance in 2, 3, 5 yrs. IMHO, I believe these recent studies have proven just the opposite conclusion that you have been trying to make since ICAAC, that resistance is enevitable. I disagree.